Fig 2: The association between FSCN1/FOXM1 and prognosis of ACC. A Overall survival for FSCN1 and FOXM1 expression (TCGA, n = 76). B Disease-free survival for FSCN1 and FOXM1 expression (TCGA, n = 76). C Univariate prognostic effects of FSCN1 and FOXM1 in subgroup analysis for OS (WCH, n = 51). D Univariate prognostic effects of FSCN1 and FOXM1 in subgroup analysis for DFS (WCH, n = 51)

Fig 3: The association between FSCN1/FOXM1 and immune signature (TIMER and GEPIA 2 analyses). a The correlation between immune cell infiltration and the expression levels of FSCN1. b The correlation between immune cell infiltration and the expression levels of FOXM1. c Co-expression of CD276/KLRB1 and FSCN1 in ACC. d Co-expression of CD276/KLRB1 and FOXM1 in ACC. e The correlation between FSCN1 signature and effector T cell and effector memory T cell signatures. f The associations between merged FSCN1/FOXM1 signature and immune related genes CD276 and KLRB1, respectively